Abstract: Disclosed are compositions and methods for inhibiting preventing, reducing delayed graft function, allograft rejection or ischemia reperfusion injury.
Type:
Grant
Filed:
February 8, 2012
Date of Patent:
April 24, 2018
Assignee:
THE TRUSTEES OF THE UNIVERSIY OF PENNSYLVANIA
Abstract: The invention provides an endometriosis mouse model wherein severely compromised immune deficient (SCID) female mice are transplanted with human xenografts of normal endometrial tissue, but result in mice with human endometriosis. Typically, the xenografts are treated with a micronized estrogen source prior to transplantation or implantation and the endogenous progesterone of the mice is eliminated also prior to transplantation of the human xenograft. These diseased mice are useful in the study of endometriosis.
Type:
Grant
Filed:
March 25, 1998
Date of Patent:
August 6, 2002
Assignees:
Reprogen, Inc., The Trustees of the Universiy of Pennsylvania
Inventors:
Jeffrey Boyd, Jerome J. Strauss, Peter Van Deerlin, Karen K. Yamamoto